Correlation Between Hillstream Biopharma and Cadrenal Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hillstream Biopharma and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hillstream Biopharma and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hillstream Biopharma and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Hillstream Biopharma and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hillstream Biopharma with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hillstream Biopharma and Cadrenal Therapeutics,.

Diversification Opportunities for Hillstream Biopharma and Cadrenal Therapeutics,

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Hillstream and Cadrenal is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Hillstream Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hillstream Biopharma are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Hillstream Biopharma i.e., Hillstream Biopharma and Cadrenal Therapeutics, go up and down completely randomly.

Pair Corralation between Hillstream Biopharma and Cadrenal Therapeutics,

If you would invest  1,419  in Cadrenal Therapeutics, Common on August 24, 2024 and sell it today you would earn a total of  80.00  from holding Cadrenal Therapeutics, Common or generate 5.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy4.35%
ValuesDaily Returns

Hillstream Biopharma  vs.  Cadrenal Therapeutics, Common

 Performance 
       Timeline  
Hillstream Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hillstream Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Hillstream Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Cadrenal Therapeutics, 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Cadrenal Therapeutics, Common are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain forward-looking signals, Cadrenal Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.

Hillstream Biopharma and Cadrenal Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hillstream Biopharma and Cadrenal Therapeutics,

The main advantage of trading using opposite Hillstream Biopharma and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hillstream Biopharma position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.
The idea behind Hillstream Biopharma and Cadrenal Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format